Summary

Overview
Saudi Arabia Wound Care Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030 growing at a CAGR of XX% during the forecast period 2023-2030.
Wound care involves every stage of wound care management which includes diagnosis and treatment of the wound by using different types of wound care management products like wound dressings. These wounds can be caused by various factors such as trauma, accidents, diabetic ulcers, infections, and others. Different wounds require different dressings such as alginate dressing, hydrocolloid dressing, etc.
Wound healing is a very important step in treating any kind of injury as this is the first and foremost step that heals the wound from the outside. The primary goal of wound care and management is to stop bleeding. This can be achieved by acute wound dressing and advanced wound dressing techniques.
Market Dynamics: Drivers & Restraints
Increasing prevalence of diabetes cases
Diabetes mellitus is a global health issue affecting millions of people worldwide. According to the National Institute of Health, it was estimated that 17.1% of adults in Saudi Arabia had diabetes in 2022. The percentage jumped from 2.1% to 7% from 1980.
Most diabetes cases lead to foot ulcers and other foot complications that need to be healed on a day-to-day basis. As diabetes has no cure, maintaining blood sugar levels and wound dressing plays a vital role in preventing leg amputations in most cases. If the wound is left without any care, it soon leads to the amputation of a part of the leg or the entire leg.
Saudi Arabia has changed in past years with modernization and urbanization which led to an increase in the consumption of processed food which has led to a rise in diabetes cases. Lifestyle change also led to an increase in cardiovascular diseases including diabetes, obesity, and other co-morbidities.
Complications with certain wound dressings
Wound dressing should hold the place because excessive moisture absorption can cause the wound to dry out. Foam dressing macerate the wound area if left for too long. Hydrocolloid dressing can lead to tissue damage where there is friction. During the removal of the dressing, there is a chance of losing healthy tissue around the wound during removal. Some of the adhesive tissue bandages don't allow wounds to heal naturally causing blisters in the surrounding area making it worse.
Segment Analysis
The Saudi Arabia wound care market is segmented based on product, wound type and end-user.
The Surgical & Traumatic Wounds segment accounted for approximately 45.3% of the market share
Increase in the number of surgical and traumatic wounds in Saudi Arabia. For instance, according to the Ministry of Health of Saudi Arabia, more than 290,000 non-critical surgeries were performed within different regions of Saudi Arabia in 2022. As many as 49,600 surgeries were performed in the Riyadh region and 8,765 in the Tabuk region.
Trauma caused due to road accidents is healed using wound care management. The Kingdom of Saudi Arabia has witnessed alarming traffic safety issues during the past few decades. Increase in the healthcare infrastructure, and upgradation in wound care management which prevent the death of the victim of traumatic injury.
According to the World Health Organization, 2023, road accidents have reduced by 35% in the last 5 years which is due to the increase in emergency wound care near the locations where accidents take place. Due to the increased focus on developing healthcare infrastructure in Saudi Arabia, the importance of wound care management and its products has been rising for the past 5 years.
COVID-19 Impact Analysis
Covid 19 impact is low on the wound care market as the fear of COVID did not restrict people from doing primary and emergency care. Wound care can easily be done in a home care setting and hence, there is not much influence of covid 19 even after the implementation of lockdown all over the world. There is a decrease in hospital visits but that did not impact on wound care market.
Market Segmentation
By Product
• Advanced Wound Dressings
• Surgical Wound Dressings
• Traditional Wound Dressings
• Film Dressings
• Alginate Dressings
• Hydrogel Dressings
• Others
By Wound Type
• Diabetic Foot Ulcer
• Surgical & Traumatic Wounds
• Venous Leg Ulcers
• Others Wounds
By End User
• Hospitals
• Home care settings
• Specialty Clinics
• Others
Competitive Landscape
The major Saudi Arabia players in the wound care market include Mölnlycke Health Care AB, SPIMACO, SHAMSAA Medical, Convatec Group PLC, Azelis Pharma, 3M, Coloplast A/S, Abbott Laboratories among others.
Key Developments
• In January 2023, Convatec launched ConvaFoam, a foam dressing designed to address the needs of healthcare providers and their patients.
• In August 2022, 3M Healthcare's Medical Solutions has advanced the delivery of 3M Veraflo Therapy. These help simplify the delivery process for clinicians and help make dressing changes easier, and faster for patients.
Why Purchase the Report?
• To visualize the Saudi Arabia wound care market segmentation based on product, wound type and end-user as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of wound care market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The Saudi Arabia wound care market report would provide approximately 30 tables, 30 figures, and 185 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Wound Type
3.3. Snippet by End-user
4. Dynamics
4.1. Impacting Factors
4.1.1. Driver
4.1.1.1. Increasing prevalence of diabetes cases
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Complications with certain wound dressings
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Surgery Statistics
5.5. Epidemiology Data
5.6. Regulatory Analysis
5.7. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Advanced Wound Dressings*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Surgical Wound Dressings
7.4. Traditional Wound Dressings
7.5. Film Dressings
7.6. Alginate Dressings
7.7. Hydrogel Dressings
7.8. Others
8. By Wound Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
8.1.2. Market Attractiveness Index, By Wound Type
8.2. Diabetic Foot Ulcer*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Surgical & Traumatic Wounds
8.4. Venous Leg Ulcers
8.5. Others Wounds
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Home care settings
9.4. Specialty Clinics
9.5. Others
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Mölnlycke Health Care AB
11.1.1. Company Overview
11.1.2. Product Type Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. SPIMACO
11.3. SHAMSAA Medical
11.4. Convatec Group PLC
11.5. Azelis Pharma
11.6. 3M
11.7. Coloplast A/S
11.8. Abbott Laboratories
LIST NOT EXHAUSTIVE
12. Appendix
12.1. About Us and Services
12.2. Contact Us